1st Quarter - Report

BROWNSTEIN HYATT FARBER SCHRECK, LLP for ELI LILLY AND COMPANY

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to the pharmaceutical industry, Issues related to COVID-19 relief H.R.1319 - American Rescue Plan Act of 2021

LobbyistCovered position, as disclosed
EMILY FELDER —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1319 (117th)

Pharmacy PHA

Issues related to the pharmaceutical industry, Issues related to COVID-19 relief H.R.1319 - American Rescue Plan Act of 2021

LobbyistCovered position, as disclosed
NADEAM ELSHAMI —
MARC LAMPKIN —
BRIAN MCKEON —
ZACHARY PFISTER —
MARK L. PRYOR New United States Senator
CARMENCITA WHONDER New Stf Dir.-Subcom on Hsg, Transp & Comm Dev; Min. Stf Director - Subcomm on Econ Policy; Legis. Corres-Offc of Sen Charles Schumer
BRIAN WILD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1319 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.